Tagged Articles

gynecomastia risks 18 articles

J&J to pay $300,000 to Virgin Islands for illegally marketing Risperdal

Johnson & Johnson and its subsidiary Janssen Pharmaceuticals have agreed to pay $300,000 to the Virgin Islands to settle claims “related to the marketing of the companies antipsychotic drug Risperdal in the Virgin Islands prior to 2008,” according to Virgin Islands Attorney General Claude Earl Walker. Risperdal, known generically as risperidone, is approved in the U.S. for the treatment of schizophrenia, bipolar disorder, and irritability with autism. It is often prescribed off label for behavioral conditions such as ADHD. In 2006, the drug was approved for pediatric use. The Virgin Islands AG’s office claims that Janssen violated the country’s Unfair ... Read More

J&J has no plans to settle the 2K lawsuits pending in Risperdal mass tort

Johnson & Johnson and its subsidiary Janssen Pharmaceuticals said they have no plans to resolve the 2,000-plus cases pending in a mass tort program Philadelphia over disfiguring side effects allegedly caused by the companies’ antipsychotic drug Risperdal despite reaching a settlement agreement in a case that was scheduled to have gone to trial this week. The terms of the settlement, reached with the family of a boy known simply as N.F., are confidential. But, given that the last Risperdal lawsuit to go to trial resulted in a landmark $70 million verdict against the company, Johnson & Johnson is eyeing the cases ... Read More

Lawyers lose fight to pull Risperdal from market over safety risks

A Philadelphia-based law firm representing boys who allege they were disfigured after taking Johnson & Johnson’s Janssen Pharmaceutical’s antipsychotic drug Risperdal has no standing to challenge the Food and Drug Administration’s (FDA) denial of a citizen’s petition asking the agency to revoke marketing approval for the drug until its long-term safety can be proven. The attorneys also asked the companies to hand over confidential documents describing the risks associated with the drug. The firm had argued that the FDA’s rejection of its citizen petition, which was filed in July 2012, led to increased cost from Risperdal-related personal injury lawsuits against ... Read More

New York man files Risperdal side effects lawsuit

A young New York man is suing Johnson & Johnson and its subsidiary Janssen Pharmaceuticals claiming the companies’ antipsychotic drug Risperdal caused him to grow female breasts, resulting in years of bullying and torment by classmates. Shaquil Byrd began taking Risperdal in 2002 at the age of 9 to treat symptoms of a severe mental health diagnosis. Within months, his mother noticed he had gained weight and developed breasts that grew large and began lactating. The condition, called gynecomastia, was humiliating for the boy, who became the subject of taunts by other kids at his school. He became insecure and self ... Read More

Johnson & Johnson slapped with back-to-back multimillion dollar verdicts linked to Risperdal, talc products

Six months after two trials resulting in multi-million dollar verdicts against Johnson & Johnson – including $112 million in punitive damages – for claims linking ovarian cancer to the genital use of its talcum powder products, the consumer health care giant was slapped with another multimillion verdict, this time by a Philadelphia jury that found the company’s antipsychotic drug Risperdal caused a young boy to grow female breasts. In all three cases, plaintiffs accused Johnson & Johnson of knowing the risks associated with its products but failed to warn the public, another classic example of Big Pharma putting profits before ... Read More

Man says he is plagued by scars from Risperdal side effects

Shaquil Byrd, 22, still has vivid memories of the bullying he endured as a preteen and teenager. “People asking if I have titties, asking if I need to wear my sister’s bra,” he told the Times Union. “They constantly asked me if I had milk.” What Shaquil had was gynecomastia, a condition in which adolescent boys grow female breast tissue. In some cases, like Shaquil’s, the breasts can become painful and lactate. His condition worsened as he grew older. Neither his doctors nor his family knew that his condition was caused by Risperdal, an antipsychotic he had been prescribed as ... Read More

Gynecomastia, breast growth in adolescent boys is emotionally, physically devastating

“My last resort is to f—ing chop the thing(s) off,” a young man who calls himself Spiderman posted to a forum on the subject of gynecomastia, a medical condition in which men grow female breasts. Gynecomastia occurs when the male body produces too much estrogen, triggering breast growth. It is generally caused by weight gain, but some medications can cause gynecomatia. The antipsychotic Risperdal, for example, has been shown in studies to trigger the production of prolactin, the hormone that causes new mothers to lactate, and that can cause boys and young men to grow breasts. Gynecomastia can be embarrassing ... Read More

Third Risperdal side effects lawsuit goes to trial

Attorneys for the plaintiff in the third Risperdal side effects lawsuit to go to trial blasted Johnson & Johnson’s unit Janssen Pharmaceuticals over illegally promoting the antipsychotic as a treatment for children with behavioral conditions. Risperdal, known generically as risperidone, is approved to treat symptoms of schizophrenia, bipolar disorder and irritability with autism. It wasn’t approved for pediatric patients until 2006. However, even before the drug was approved for children and adolescents with those conditions, Janssen pushed its sales force to market the drug to doctors for off-label uses. Doctors have the discretion to prescribe drugs for conditions or patients ... Read More

‘Docu-Serial’ follows Risperdal’s controversial past

Veteran reporter Steve Brill is targeting Johnson & Johnson and its controversial history with the antipsychotic Risperdal in a provocative, 15-chapter, 59,000-word “docu-serial” titled “America’s Most Admired Lawbreaker,” which is being published in chapters in the Huffington Post. The first chapter, titled “The Credo Company,” mocks Johnson & Johnson’s 308-word mission statement, which essentially states, “Patients first, profits last.” However, Brill’s investigation into the inner workings of the consumer health care giant question the authenticity of that statement. Brill explains that while Johnson & Johnson is most known by its consumer brands, including Tylenol, Listerine, Nutrogena and, of course, Johnson’s ... Read More

Children taking Risperdal at risk of serious side effects

An increasing number of teenagers are being prescribed antipsychotic medications such as Risperdal, which raises concerns because the drugs can have long-term adverse effects. Risperdal, known generically as risperidone, is FDA-approved to treat adults and children with schizophrenia, bipolar disorder and irritability with autism. It is also often prescribed off label for behavior problems including ADHD and ADD. Medications are approved by the FDA for uses based on safety and efficacy data provided by drug companies. The FDA has determined that drugs like Risperdal can be effective for treating adults and children, and the agency also identifies potential side effects ... Read More